Related references
Note: Only part of the references are listed.Viral suppression rate among children tested for HIV viral load at the Amhara Public Health Institute, Bahir Dar, Ethiopia
Melashu Balew Shiferaw et al.
BMC INFECTIOUS DISEASES (2019)
Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study)
Joseph Fokam et al.
BMC PEDIATRICS (2019)
Clinical outcomes of a cohort of migrants and citizens living with human immunodeficiency virus in Botswana: implications for Joint United Nation Program on HIV and AIDS 90-90-90 targets
Tafireyi Marukutira et al.
MEDICINE (2019)
Developments in early diagnosis and therapy of HIV infection in newborns
Francisco Canals et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
Shortening the decade-long gap between adult and paediatric drug formulations: a new framework based on the HIV experience in low- and middle-income countries
Martina Penazzato et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2018)
Effects of Low- and High-Mineral Content Water on the Relative Bioavailability of a Coformulated Abacavir/Dolutegravir/Lamivudine Dispersible Tablet in Healthy Adults
Rajendra P. Singh et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2018)
HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration
Awachana Jiamsakul et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
Relative Bioavailability of a Dolutegravir Dispersible Tablet and the Effects of Low- and High-Mineral-Content Water on the Tablet in Healthy Adults
Ann M. Buchanan et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)
Relative bioavailability of a paediatric granule formulation of the HIV integrase inhibitor dolutegravir in healthy adult subjects
Parul Patel et al.
ANTIVIRAL THERAPY (2014)
Pharmacokinetics of the HIV integrase inhibitor S/GSK1349572 co-administered with acid-reducing agents and multivitamins in healthy volunteers
Parul Patel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)